Phase 3 Study of Novavax Vaccine(s) as Booster Dose After mRNA Vaccines

NCT05875701 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

147

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: NVX-CoV2373
BIOLOGICAL: SARS-CoV-2 rS antigen/Matrix-M Adjuvant

Sponsor

Novavax